Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
D'Silva Andrew J. (CIK 2083717) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-02). Recent activity: Sell OPRX (1,432 shares), Buy OPRX (57,600 shares), Sell OPRX (1,243 shares), Sell OPRX (703 shares), Sell OPRX (868 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | OptimizeRx Corp (OPRX) | Chief Business Officer | Sell | 1,432 | $11,256 |
| 2026-08-24 | OptimizeRx Corp (OPRX) | Chief Business Officer | Buy | 57,600 | $0 |
| 2026-08-24 | OptimizeRx Corp (OPRX) | Chief Business Officer | Sell | 1,243 | $9,584 |
| 2025-12-22 | OptimizeRx Corp (OPRX) | Chief Business Officer | Sell | 703 | $9,498 |
| 2025-12-15 | OptimizeRx Corp (OPRX) | Chief Business Officer | Sell | 868 | $12,178 |
| 2025-11-07 | OptimizeRx Corp (OPRX) | Chief Business Officer | Sell | 414 | $7,858 |
| 2025-11-07 | OptimizeRx Corp (OPRX) | Chief Business Officer | Sell | 794 | $14,888 |
| 2025-10-07 | OptimizeRx Corp (OPRX) | Chief Business Officer | Buy | 10,417 | $0 |
Source: SEC Form 4 filings · as of 2026-09-02